Deferred Tax Assets, Net of Valuation Allowance in USD of Vaxxinity, Inc. from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Vaxxinity, Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance history and change rate from Q4 2020 to Q4 2023.
  • Vaxxinity, Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2023 was $42K, a 50% decline year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

Vaxxinity, Inc. Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2023 $42K -$42K -50% 31 Dec 2023 10-K 27 Mar 2024
Q4 2022 $84K +$23K +37.7% 31 Dec 2022 10-K 27 Mar 2024
Q4 2021 $61K -$69K -53.1% 31 Dec 2021 10-K 27 Mar 2023
Q4 2020 $130K 31 Dec 2020 10-K 24 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.